Pharmacokinetic and pharmacodynamic properties of TRU-015, a CD20-directed small modular immunopharmaceutical protein therapeutic, in patients with rheumatoid arthritis: A phase I, open-label, dose-escalation clinical study

✍ Scribed by Daniel J. Burge; Stephen A. Bookbinder; Alan J. Kivitz; Roy M. Fleischmann; Cathye Shu; Jeannette Bannink

• Book ID: 116372233
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 146 KB
• Volume: 30
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2008.10.017